Kevin Saunders Named Norman L. Letvin M. D. Distinguished Professor in Surgery and the Duke Human Vaccine Institute


This spring, 18 faculty members in the Duke University School of Medicine have been awarded distinguished professorships. The new distinguished professors will be honored at the annual distinguished professorship event on May 23, 2024.   

In total, 32 new distinguished professors across Duke University were approved by the Board of Trustees in February. 

Distinguished professorships are awarded to faculty who have demonstrated extraordinary scholarship in advancing science and improving human health.   

Kevin Saunders, PhD, is a professor in surgery who also has appointments in integrative immunobiology and molecular genetics and microbiology. His research focuses on vaccine and antibody development to combat HIV-1 infection and coronavirus infections. As the associate director of the Duke Human Vaccine Institute (DHVI) and director of the DHVI Laboratory of Protein Expression, he focuses on two main areas of research: vaccine design and antibody isolation and engineering. Together, his research program is an interdisciplinary approach to understanding the molecular biology underlying antibody recognition of glycoproteins in order to produce protective vaccines. 

Read more about the faculty members awarded distinguished professorships.